Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
vm202 (1 trial)
Diabetic Neuropathies (Phase 3)
Pain (Phase 3)
Peripheral Nervous System Diseases (Phase 3)
Trials (1 total)
Trial APIs (1 total)